Short Interest in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Decreases By 66.6%

Posted by ABMN Staff on Jul 26th, 2026

Fidelity Disruptive Medicine ETF (NASDAQ:FMED – Get Free Report) was the target of a significant decline in short interest in July. As of July 15th, there was short interest totaling 756 shares, a decline of 66.6% from the June 30th total of 2,265 shares. Approximately 0.0% of the company’s stock are sold short. Based on an average daily volume of 11,543 shares, the days-to-cover ratio is currently 0.1 days.

Fidelity Disruptive Medicine ETF Trading Down 0.7%

Fidelity Disruptive Medicine ETF stock opened at $28.34 on Friday. The company has a market cap of $45.34 million, a P/E ratio of 41.33 and a beta of 0.74. Fidelity Disruptive Medicine ETF has a 1-year low of $22.80 and a 1-year high of $30.33. The company has a fifty day simple moving average of $26.83 and a 200 day simple moving average of $26.09.

Hedge Funds Weigh In On Fidelity Disruptive Medicine ETF

A number of large investors have recently modified their holdings of FMED. Jane Street Group LLC grew its holdings in shares of Fidelity Disruptive Medicine ETF by 0.8% in the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock valued at $1,567,000 after acquiring an additional 499 shares in the last quarter. BXM Wealth LLC acquired a new stake in shares of Fidelity Disruptive Medicine ETF in the fourth quarter valued at about $243,000. Glass Jacobson Investment Advisors llc raised its holdings in Fidelity Disruptive Medicine ETF by 44.0% during the fourth quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock worth $34,000 after acquiring an additional 385 shares in the last quarter. Vise Technologies Inc. bought a new stake in Fidelity Disruptive Medicine ETF during the fourth quarter worth about $234,000. Finally, Virtu Financial LLC acquired a new position in Fidelity Disruptive Medicine ETF during the fourth quarter valued at approximately $228,000.

About Fidelity Disruptive Medicine ETF

(Get Free Report)

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.